Back

FLNC pathogenic variants in patients with various cardiomyopathies:prevalence and genotype-phenotype correlations

1 September 2019 (10:05 - 10:55)
Organised by:
Congress Presentation Part of: Clinical, imaging and genetic advances in hypertrophic cardiomyopathy Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Flavie Ader

Pitie Salpetriere APHP University Hospital, Paris (France)

5 More presentations in this session

Presentation thumbnail
Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy.
Doctor C. Fumagalli (Naples, IT)
Abstract Slides
Presentation thumbnail
Survival after septal myectomy in male and female patients with hypertrophic obstructive cardiomyopathy
Mr R. Huurman (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability
Professor I. Ostman-Smith (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Myocardial transit time (MTT) - a novel and easy-to-perform CMR parameter to assess microvascular disease.
Mr G. Chatzantonis (Munster, DE)
Abstract Slides
Presentation thumbnail
Characteristics and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy
Doctor K. Choi (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
Clinical, imaging and genetic advances in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2019

1 September 2019 10:05 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources